Free Trial

Kelly CRISPR & Gene Editing Technology ETF (XDNA) News Today

Kelly CRISPR & Gene Editing Technology ETF logo
$7.38 0.00 (0.00%)
As of 09/9/2025

XDNA Latest News

K-12 Genome Editing at Only $2 a Pop
CRISPR Technology Takes Center Stage at SXSW 2024 for the First Time
Gene editing is now a medical reality
3 Biotech Stocks That Are Betting on the Future of Gene Editing
Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Megatrends: Gene Therapy and Editing
Genome Editing Technologies Market Report 2022-2032
Unlocking the Potential of Gene Editing
3 Sectors You Might Have Missed with Upside (XDNA)
Thematic ETFs are poised to become more important vehicles for accessing subindustries in very targeted ways that are not possible with broad sector funds.
Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XDNA Media Mentions By Week

XDNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XDNA
News Sentiment

0.00

1.37

Average

News Sentiment

XDNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XDNA Articles
This Week

0

0

XDNA Articles
Average Week

Get the Latest News and Ratings for XDNA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kelly CRISPR & Gene Editing Technology ETF and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:XDNA) was last updated on 9/11/2025 by MarketBeat.com Staff
From Our Partners